There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

RiverStone Health encourages everyone to receive the updated COVID-19 vaccine as recommended by the Centers for Disease ...

The Novavax COVID-19 vaccine is set to finally receive full approval from the FDA. The agency said Novavax must collect more ...

Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one change each year to their recipe — which strain to target — just like flu vaccines.

A group of former BlueCross BlueShield of Tennessee employees allegedly fired after declining to get the COVID-19 vaccine for ...

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...